Insider · CIK 0002083717
Andrew J. D'Silva
Files at OPRX (OptimizeRx Corp). First filing -, latest -.
In brief
Andrew J. D'Silva files SEC Form 4 as officer at OPRX (OptimizeRx Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andrew J. D'Silva has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -414 | $8.39 | $3,473 | 99,246 | 11 d ago |
| Sep 1, 2026 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,432 | $7.86 | $11k | 99,660 | 41 d ago |
| Aug 21, 2026 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,243 | $7.71 | $9,584 | 43,492 | Aug 24, 2026 |
| Aug 20, 2026 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +57,600 | $0.00 | $0 | 101,092 | Aug 24, 2026 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -703 | $13.51 | $9,498 | 44,735 | Dec 22, 2025 |
| Dec 11, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -868 | $14.03 | $12k | 45,438 | Dec 15, 2025 |
| Oct 1, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -414 | $18.98 | $7,858 | 47,100 | Nov 7, 2025 |
| Oct 3, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -794 | $18.75 | $15k | 46,306 | Nov 7, 2025 |
| Aug 21, 2025 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +10,417 | $0.00 | $0 | 47,514 | Oct 7, 2025 |
| Aug 21, 2025 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +23,437 | $0.00 | $0 | 23,437 | Oct 7, 2025 |
Questions about Andrew J. D'Silva
Answered from the filings on this page, as of the latest one.
Is Andrew J. D'Silva buying or selling?
Andrew J. D'Silva has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andrew J. D'Silva's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew J. D'Silva has 0.
Where does Andrew J. D'Silva file Form 4?
Andrew J. D'Silva has filed Form 4 at OPRX (OptimizeRx Corp) as Chief Business Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.